Literature DB >> 27239145

Alterations of erythrocyte ATPase activity and oxygen consumption in patients with liver-blood deficiency syndrome.

L J Shi1, J F Liu1, Z Q Zhang1, Y Q Lu1, Y G Shu1, G L Chen1, Z H Xin1, J Y Xu1.   

Abstract

AIM: To investigate the pathophysiology of erythrocyte energy metabolic changes of patients with the traditional Chinese Medicine (TCM) liver-blood deficiency syndrome (LBDS).
METHODS: Erythrocyte membrane ATPase activity and oxygen consumption rate (OCR) were determined in 66 patients with LBDS, including 35 patients with iron deficiency anemia and 31 patients with chronic aplastic anemia. Thirty healthy adults served as controls.
RESULTS: ATPase activity and OCR were decreased in patients with LBDS.
CONCLUSION: The decreased erythrocyte ATPase activity and OCR might cause the energy hypometabolism in LBDS patients.

Entities:  

Keywords:  Adenosine triphosphatase; Aplastic anemia; Cell membrane; Iron-deficiency anemia; Liver-blood deficiency syndrome; Oxygen consumption; erythrocytes

Year:  1997        PMID: 27239145      PMCID: PMC4842886          DOI: 10.3748/wjg.v3.i3.180

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  Standardized method for the determination of human erythrocyte membrane adenosine triphosphatases.

Authors:  M Reinila; E MacDonald; N Salem; M Linnoila; E G Trams
Journal:  Anal Biochem       Date:  1982-07-15       Impact factor: 3.365

Review 2.  The red cell membrane and its cytoskeleton.

Authors:  W B Gratzer
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

3.  Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension.

Authors:  H E de Wardener; G A MacGregor
Journal:  Kidney Int       Date:  1980-07       Impact factor: 10.612

4.  Effect of thyroid status on ouabain binding to the human lymphocyte.

Authors:  R D Arnott; R White; G Jerums
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.